Giuseppe Bardi
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 11
- Immunology 15
- Immunotherapy and Immune Responses 10
- Co-authors
- Pier Paolo PompaFrancesca GattoElisa De LucaMarco BaggioliniMauro MoglianettiPius LoetscherTommaso PizzorussoDeborah Pedone
- Journals
- Nanomaterials (5 papers)Nanomedicine Nanotechnology Biology and Medicine (3 papers)Nanomedicine (2 papers)The Journal of Immunology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Giuseppe Bardi
64 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 146
- Biomaterials 678
- Immunology 839
- Pollution 291
- Pharmaceutical Science 135
- Materials Chemistry 974
Countries citing papers authored by Giuseppe Bardi
This map shows the geographic impact of Giuseppe Bardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Bardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Bardi more than expected).
Fields of papers citing papers by Giuseppe Bardi
This network shows the impact of papers produced by Giuseppe Bardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Bardi. The network helps show where Giuseppe Bardi may publish in the future.
Co-authors
The 25 scholars most cited alongside Giuseppe Bardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 32 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 13 | |
| 7 | 2020 | 8 | |
| 8 | 2017 | 11 | |
| 9 | 2015 | 6 | |
| 10 | 2013 | 21 | |
| 11 | 2013 | 31 | |
| 12 | 2012 | 122 | |
| 13 | 2009 | 46 | |
| 14 | 2009 | 10 | |
| 15 | 2008 | 52 | |
| 16 | 2006 | 50 | |
| 17 | 2003 | 58 | |
| 18 | 2002 | 364 | |
| 19 | 2001 | 245 | |
| 20 | 2001 | 107 |
About Giuseppe Bardi
Giuseppe Bardi is a scholar working on Biomaterials, Immunology, Pharmaceutical Science, Neurology and Developmental Neuroscience, having authored 65 papers that have together received 3.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Chemokine receptors and signaling (13 papers), Nanoparticle-Based Drug Delivery (11 papers), Graphene and Nanomaterials Applications (10 papers), Immunotherapy and Immune Responses (10 papers), Advanced biosensing and bioanalysis techniques (9 papers), Nanoparticles: synthesis and applications (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Biomaterials (678 citations), Immunology (839 citations), Pollution (291 citations), Pharmaceutical Science (135 citations) and Materials Chemistry (974 citations). Giuseppe Bardi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Pier Paolo Pompa, Francesca Gatto, Elisa De Luca, Marco Baggiolini, Mauro Moglianetti, Pius Loetscher, Tommaso Pizzorusso, Deborah Pedone, Ian Clark‐Lewis and Lisa Gherardini. Their work appears in journals such as Nanomaterials, Nanomedicine Nanotechnology Biology and Medicine, Nanomedicine, The Journal of Immunology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.